We envision a world where all people have access to quality-assured sexual and reproductive health medicines and technologies

Pregnant women must not be excluded from clinical trials to ensure new medicines are developed

Join us as we call for pregnant women to be included in clinical trials #onlytwodrugsever

Find out more about AIM and other ongoing projects

ACCELERATING INNOVATION FOR MOTHERS

In partnership with the Bill & Melinda Gates Foundation, we are engaging with key stakeholders in the pharmaceutical industry and public health field to assess the interest in establishing a Research Consortium including donors, manufacturers, procurers, academia and consumer organizations for new innovations in maternal health.

The main scope of the AIM project are the following conditions: preterm labor/birth, preeclampsia/ eclampsia, impaired fetal growth, intrapartum fetal distress, and postpartum hemorrhage (PPH).

self administration of SRH products

With funding from WHO, we are undertaking research and reporting on the regulatory situation and availability of self-care SRH products in 25 countries, with a focus on contraceptives, emergency contraception, selected fertility products and diagnostic tests for pregnancy, ovulation and HPV.

Concept Foundation launches #ONLYTWODRUGSEVER

For many women around the world, pregnancy is a time of joy, but it can also be a time of confusion and fear. Whether it is the common cold or something potentially more concerning, like pre-eclampsia, women are often faced with uncertainty and even confusing advice...

Accelerating Innovation For Mothers

Our mission is to define and implement pathways for accelerating development and introduction of innovative products for pregnancy-specific conditions through global partnerships.
Click “Read More” to access the AIM website’

Market Assessment for Medical Abortion Drugs in Argentina

In 2020 and 2021 Concept Foundation worked closely with Centro de Estudios de Estado y Sociedad (CEDES) in Argentina, to conduct a market assessment to identify possible barriers and challenges to accessing quality assured and affordable medical abortion supplies and...

ANNUAL REPORT 2020

Main activities and impact. While most of 2020 was disrupted by the COVID-19 pandemic, we were able to generate new projects and grants towards the end of the year. Our maternal health portfolio expanded significantly in 2020 while we continued with our contraception...

Concept Foundation contributes to new regulatory guidance released by WHO for ensuring quality of Oxytocin in LMICs

WHO publishes for the first time a set of dedicated regulatory guidelines for national medicines authorities in low-and middle-income countries (LMICs) to evaluate and set quality standards for oxytocin, an essential maternal health drug used for the prevention and...

Effectiveness of uterine tamponade devices for refractory postpartum haemorrhage after vaginal birth: a systematic review

Haemorrhage continues to be the most significant direct cause of maternal death, accounting for 661 000 deaths worldwide between 2003 and 2009. Most of these deaths occur during the immediate postpartum period and are due to uterine atony, a condition characterised by...

Concept Foundation is an international not for profit organization, working on improving access to sexual and reproductive health medicines and technologies in low- and middle-income countries worldwide.

 

Founded in 1989, we operate under a collaboration agreement with the World Health Organization to promote the availability of sexual and reproductive health products at affordable prices, and their safe and effective use in low-resource settings.

PHOTO: STELLA, COMMUNITY HEALTH WORKER, UGANDA

CREDIT: JONI KABANA

Concept Foundation is an international not for profit organization, working on improving access to sexual and reproductive health medicines and technologies in low- and middle-income countries worldwide.

 

Founded in 1989, we operate under a collaboration agreement with the World Health Organization to promote the availability of sexual and reproductive health products at affordable prices, and their safe and effective use in low-resource settings.

PHOTO: STELLA, COMMUNITY HEALTH WORKER, UGANDA

CREDIT: JONI KABANA